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The efficacy of verapamil and lidocaine for treating isch-
emia-induced arrhythmias was determined in a con-
scious canine model with a previous myocardial infarc-
tion remote from the ischemic area. Temporary (up to 
5.5 minutes) occlusion of the circumflex coronary artery 
was made in eight conscious dogs that had sustained an 
anterior myocardial infarction 13 to 35 days previously. 
Each dog served as its own control. Ventricular ar-
rhythmias were observed in 100% of control experi-
ments but in only 25 % of experiments after verapamil 
pretreatment at 0.4 mg/kg body weight. Repetitive ven-
tricular complexes, defined as two or more consecutive 
ventricular complexes terminating spontaneously in si-
nus rhythm, were seen in 88% of control experiments 
and 13% ofverapamil experiments, whereas ventricular 
Clinical studies of patients with cardiac arrest who were 
resuscitated out-of-hospital and who have acute myocardial 
infarction have suggested that ventricular fibrillation fre-
quently occurs within a few minutes after coronary flow is 
compromised (1-4). The abruptness with which such ar-
rhythmia strikes makes it particularly difficult to perform 
clinical studies. Although there are clinical data from pa-
tients with a previous myocardial infarction indicating that 
prophylactic beta-adrenergic blocking agents are effective 
in reducing the incidence of subsequent death, the utility of 
other prophylactic pharmacologic interventions including 
therapy with the traditional antiarrhythmic agents that block 
the so-called fast sodium channel remains unproven (5,6). 
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fibrillation was seen in 6% of control experiments but 
in no verapamil experiment. Thus, verapamil abolished 
arrhythmias or reduced the grade of arrhythmias in all 
dogs. 
Six of the eight dogs were also tested with lidocaine 
pretreatment at one or two doses resulting in mean plasma 
levels of 3.8 ± 2.0 #Lg/ml. Ventricular arrhythmias were 
seen in 92% of control experiments and 100% of lido-
caine experiments. The incidence of ventricular fibril-
lation increased from 8% in control to 60% in lidocaine 
experiments. It is concluded that verapamil may prevent 
severe ischemia-induced arrhythmias after a recent myo-
cardial infarction, whereas lidocaine may in some cases 
aggravate arrhythmias. 
(J Am Coli CardioI1985;6:674-81) 
The purpose of this study is to compare pretreatment with 
a slow (calcium) channel blocker, verapamil, with pretreat-
ment with a fast (sodium) channel blocker, lidocaine, in a 
conscious canine model of sudden coronary death due to 
coronary occlusion in a heart with a previous myocardial 
infarction. 
The ischemia-induced arrhythmias observed within min-
utes of occlusion in animal models are thought to be anal-
ogous to these lethal clinical arrhythmias (7-9). Previous 
studies (10-13) in animal models have shown that verapamil 
pretreatment has a protective effect against ventricular ar-
rhythmias produced by ischemia. Pretreatment with lido-
caine has not been consistently demonstrated to be beneficial 
(14-17). However, these observations were made on ven-
tricular arrhythmias after abrupt coronary occlusion in open 
chest animals and these are influenced by altered sympa-
thetic tone and by the effects of anesthesia. Because altered 
sympathetic tone and anesthesia may affect these arrhyth-
mias, it is important to confirm such data in a conscious 
animal model more analogous to the clinical state (18-20). 
The present model also differs from previous models in that 
ischemia is produced in the presence of a previous myo-
cardial infarction. 
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Methods 
Experimental model. Twenty-two adult mongrel dogs 
of both sexes weighing 18 to 22 kg were selected on the 
basis of apparent good health and reasonable disposition. 
They were anesthetized intravenously with sodium pento-
barbital, 30 mg/kg body weight. Using sterile surgical tech-
nique, the thorax was opened through the fourth left inter-
costal space. A balloon occluder developed by Barger (Hazen 
Everett Co.) was placed around the proximal left circumflex 
coronary artery. An acrylic plaque, 5 x 7 x 2 mm, con-
taining five silver contacts was sutured to the left ventricular 
epicardium in the distribution of the circumflex coronary 
artery. These electrodes were later used for recording bipolar 
electrograms from the future ischemic epicardium. Two ad-
ditional silver electrodes were buried subcutaneously to re-
cord an electrocardiogram. The inflation tubing for the oc-
clusive balloon and connections for the recording electrodes 
were externalized through skin buttons between the scapulae. 
In 16 dogs a two-stage permanent coronary ligation was 
made on the left anterior descending artery distal to the first 
large diagonal branch. Of these 16 dogs, 2 died at the time 
of surgery because of ventricular fibrillation after the coro-
nary artery was ligated and 3 more died within the next 72 
hours of uncertain causes, possibly as a result of arrhythmia. 
Thus, II of these 16 dogs survived to be tested according 
to the experimental procedure described later. In six addi-
tional dogs the more distal left anterior descending artery 
was ligated and ligatures were placed distally on all visible 
branches of that vessel. None of these dogs died in the early 
postoperative period; however, one was sacrificed on the 
II th postoperative day after it developed a refractory in-
fection. Thus, five of these dogs went on to be tested. 
Myocardial infarction in the distribution of the left anterior 
descending artery was confirmed at subsequent postmortem 
examination in all dogs surviving the early postoperative 
course, even though two variations of surgical technique 
were used. All of these dogs showed a rapid ventricular 
tachycardia which was usually polymorphic on brief (30 
seconds to a few minutes) electrocardiographic recording 
done 24 hours postoperatively. By the fourth or fifth post-
operative day, sinus rhythm was observed without ventric-
ular ectopic depolqrizations. Althol.!gh two variations of sur-
gical technique were used to produce the anterior infarction 
to attempt to find the best long-term model, each dog became 
its own control in subsequent experiments. 
Experimental procedure. Dogs were trained to stand 
quietly in a sling by repeated exposure to the laboratory 
environment. Experiments were performed between 13 and 
35 days after surgery at which time all dogs seemed to have 
recovered from the effects of surgery. The electrocardio-
gram qnd electrograms were recorded on an Electronics for 
Medicine DR-12 recorder and a Hewlett-Packard 3944 mag-
netic recording system (used for the first two dogs). In the 
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last six dogs recordings were made with an Electronics for 
Medicine VR-12 recorder and a Hewlett-Packard 3960 mag-
netic recording system. Constant pressure for inflating the 
occlusive balloon was provided from a compressed air tank 
through a Matheson I-H line regulator. 
Each occlusion of the circumflex coronary artery was 
begun approximately 45 to 60 minutes after the dog had 
been placed into the sling. The electrocardiogram and two 
sets of epic~rdial bipolar electrocardiograms in the circum-
flex distribution were recorded continuously before, during 
and after the occlusion. Electrograms were recorded be-
tween filter frequencies of 30 and 500 Hz at a paper speed 
of 100 mm/s. The occlusion was abfl.!ptiy begun by turning 
a stopcock in the line between the compressed air tank and 
the tubing from the occlusive balloon. The occlusion was 
abruptly terminated immediately after the appearance of 
repetitive ventricular complexes, defined as two or more 
consecutive ventricular complexes, or after a maximal pe-
riod of 5.5 minutes after the onset of occlusion. 
Verapamil and lidocaine testing. The effect of either 
verapamil or lidocaine was compared with the results' of 
preceding and subsequent control occlusions. Each of eight 
dogs underwent a sequence of I) control, 2) verapamil, and 
3) control experiments. Of these eight dogs, six were also 
tested with lidocqine at one dose or at two different doses 
(four were tested with two doses). Thus, there were 10 
lidocaine experiments in six dogs. Sequences for these ex-
periments are noted in Figure I. Each dog, therefore, served 
as its own control. 
Verapamil was given intravenously at 0.4 mg/kg body 
weight over 10 minutes and the occlusion was begun 10 
minutes after the infusion was completed. Lidocaine was 
given intravenously as I) an initial loading dose of 2 mg/kg 
body weight 2) a second loading dose of I mg/kg 20 minutes 
later, and 3) a maintenance infusi~n of 70 to 200 JLg/~g per 
min which was started when the initial loading dose was 
given. Plasma lidocaine levels were drawn within 5 minutes 
after the occlusion was terminated while the maintenance 
I 
infusion was running. Lidocaine concentrations were de-
termined by a polarized fluorescent method (Abbott 
Diagnostics) . 
Data analysis. Observations were made on the highest 
grade of ventricular arrhythmia observed before release of 
the occlusion. The highest grade of arrhythmia observed 
was stratified as I) single ventricular premature depolari-
zations, 2) repetitive ventric4!ar complexes defined as two 
or more consecutive ventriqJlar complexes that reverted 
spontaneously to sinus rhythm, and 3) ventricular fibrillation 
with onset before release. All but one episode of ventricular 
fibrillation were terminated by defibrillation with 50 to 
100 J delivered by external paddles. 
The latency from onset of occlusion to appearance of 
arrhythmia was defined as the time in seconds from the 
onset of occlusion until any ventricular arrhythmia appeared 
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Figure 1. Incidence of the highest grade of ventricular arrhythmia 
observed during coronary occlusion. Each of eight dogs underwent 
a sequence of control (C I), verapamil (V) and second control (C2) 
experiments. Note that most dogs had no ventricular arrhythmia 
during verapamil occlusion. Six of these eight dogs were also tested 
in another sequence of control (Cd, lidocaine (L) at one dose or 
at two different doses and a second control (C l ) experiment. The 
lidocaine sequences were as follows: dog A: not tested; dog B: 
control, lidocaine at dose I, lidocaine at dose 2, control; dog C: 
not tested; dog D: control, lidocaine at dose I, lidocaine at dose 
2 (not resuscitated); dog E: control, lidocaine at dose I, lidocaine 
at dose 2, control; dog F: control, lidocaine at dose I, control; 
dog G: control, lidocaine at dose I, control; dog H: control, lido-
caine at dose I, control, lidocaine at dose 2, control. Thus, there 
were 7 control experiments before lidocaine administration and 10 
lidocaine experiments but only 6 second control experiments be-
cause one dog had ventricular fibrillation unresponsive to attempted 
defibrillation during a lidocaine occlusion. VPD's = ventricular 
premature depolarizations. 
or until release of the occlusion if no ventricular arrhythmia 
appeared. The effect of an intervention (that is, either ve-
rapamil or lidocaine) on latency was measured as the dif-
ference between the intervention latency and the average 
control latency and expressed as a percent of the average 
control latency. 
Observations were made on the effect of verapamil and 
lidocaine on sinus rate before occlusion and on peak sinus 
rate during occlusion. 
The effect of coronary occlusion on epicardial conduction 
delay within the ischemic zone was examined. Epicardial 
conduction delay was defined as the interval from the onset 
of the QRS of the surface electrocardiogram to the first rapid 
deflection of the bipolar electrogram as it crossed the base-
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line. The electrogram was located in the circumfleX coronary 
artery distribution which would become ischemic during 
coronary occlusion. Two pairs of bipolar electrodes were 
arranged perpendicularly to one another on the acrylic plaque. 
Conduction delay was measured using each pair of elec-
trodes. The electrode pair that demonstrated the greater change 
during control occlusion was used for subsequent comparisons. 
The rate at which conduction delay changed with coro-
nary occlusion was examined. The rate of change of con-
duction delay was not observed to be constant during serial 
occlusions. Therefore, to allow comparisons between con-
trol and intervention experiments, the peak conduction delay 
(in milliseconds) achieved during occlusion divided by the 
time elapsed from start of occlusion to the time at which 
peak delay was achieved (in seconds) was used as a measure 
of the rate of change for conduction delay. 
Statistical analysis. Where applicable, results have been 
given as mean and standard error of the mean. Values ob-
tained from the same dog were compared using paired com-
parison mean t test. Significance was established when the 
probability value was less than 0.05. 
Results 
Nine of the 16 instrumented dogs that were tested had 
ventricular arrhythmias on repeated control occlusions. One 
of these nine dogs had bradycardia and loss of consciousness 
during repeated control occlusions and was excluded from 
the data. The data were obtained from the remaining eight 
dogs. Of these eight, seven had the two-stage ligation of 
the proximal left anterior descending artery and one had 
ligation of the distal left anterior descending artery and its 
branches. 
Changes in ventricular arrhythmia. The incidence of 
repetitive ventricular complexes during occlusion was re-
duced by verapamil (Fig. 1). Ventricular fibrillation during 
occlusion was not observed in any verapamil experiment 
and was only seen in one control experiment for verapamil 
sequences. Ventricular fibrillation during occlusion was ob-
served in 6 of 10 lidocaine experiments as compared with 
only 1 of 13 control experiments (Fig. I). Lidocaine, there-
fore, was associated with an increased incidence of ven-
tricular fibrillation during occlusion. 
Plasma lidocaine levels did not significantly differ in 
those experiments that resulted in ventricular fibrillation 
from those that did not (Table I). Mean lidocaine levels 
were 3.8 ± 0.6 ILg/ml for the entire group, 3.5 ± 0.7 
ILg/ml for the six experiments resulting in ventricular fi-
brillation and 4.2 ± 1.3 ILg/ml for the four experiments 
without ventricular fibrillation. 
Changes in latency. The mean (± SE) latency period 
from onset of occlusion to the appearahce of the first ven-
tricular arrhythmia for all control experiments was 116 ± 
10 seconds. Thus, ventricular arrhythmias appeared very 
lACC Vol. 6, No.3 
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Table 1. Effect of Lidocaine on Latency From Onset of 
Coronary Occlusion to Appearance of Ventricular Arrhythmia 
in Six Dogs 
Lidocaine 
Level Latency Percent 
Dog Occlusion (ltg/m!) (seconds) Change 
B Control 80 
Lidocainet 2.4 149 +99 
Control 70 
B Control 80 
Lidocainet 4,3 77 +3 
Control 70 
D Control 113 
Lidocainet 1.4 87 -23 
Control:j: 
D Control 113 
Lidocainet 2.5 65 -42 
Control:j: 
E Control 149 
Lidocaine 1.2 122 + 13 
Control 67 
E Control 149 
Lidocainet 6.4 97 -·10 
Control 67 
F Control 117 
Lidocaine 7.4 158 +34 
Control 119 
G Control 330 
Lidocainet 4.1 30 -88 
Control 182 
H Control 175 
Lidocaine 4.0 203 +34 
Control 127 
H Control 127 
Lidocaine 4.2 131 -9 
Control 161 
Mean ± standard error +1 ± 15.8* 
*p = not significant. tVentricular fibrillation was observed in these 
lidocaine experiments. :j:Control occlusion after lidocaine was not per-
formed because the dog could not be resuscitated from ventricular fibril-
lation during the lidocaine occlusion (at higher dose). 
early after occlusion. After verapamil administration, the 
latency increased significantly when compared with control 
in all dogs tested (Table 2). However, arrhythmias appeared 
in only two dogs pretreated with verapamil; arrhythmias 
were delayed in those two dogs and the grade of arrhythmias 
was also reduced. Lidocaine did not have a consistent effect 
on the duration of the latency period; it increased in five 
experiments and decreased in five experiments (Table 1). 
Changes in heart rate. Sinus rate before coronary oc-
clusion was 136 ± 12 beats/min (mean ± SE) after ve-
rapamil administration versus 120 ± 9 beats/min before 
verapamil and 132 ± 12 beats/min after lidocaine versus 
133 ± 14 beats/min before lidocaine. These changes did 
not reach significance. 
Peak sinus rate during occlusion was 172 ± 10 beats/min 
TEMESY -ARMOS ET AL. 677 
VERAPAMIL AND LIDOCAINE IN ISCHEMIC ARRHYTHMIAS 
for verapamil experiments versus 187 ± 12 beats/min for 
control experiments and 185 ± 10 beats/min for lidocaine 
experiments versus 176 ± 9 beats/min for control experi-
ments. These changes did not reach significance. In two of 
eight verapamil experiments second degree atrioventricular 
block was observed during ischemia. All other experiments 
demonstrated 1: 1 atrioventricular conduction. 
During a verapamil experiment one dog developed typ-
ical sinus tachycardia initially after the onset of occlusion; 
however, at 205 seconds after the start of occlusion, junc-
tional brachycardia at a rate of 40 beats/min developed and 
the dog became limp and unresponsive. The dog quickly 
regained consciousness after release of occlusion. This same 
dog did not demonstrate bradycardia during control or lid-
ocaine experiments. However, all of these occlusions were 
terminated sooner (in less than 205 seconds) when repetitive 
ventricular complexes appeared. 
Change in conduction delay to the ischemic epicar-
dium. Verapamil. Recordings were adequate to measure 
epicardial conduction delay before and during occlusion in 
six of eight dogs tested with verapamil. Conduction delay 
increased with occlusion during control experiments in five 
of six dogs. The mean increase in conduction delay was 
less during verapamil occlusion (47% increase of preocclu-
Table 2. Effect of Verapamil on Latency From Onset of 
Occlusion to Appearance of Ventricular Arrhythmia in 
Eight Dogs 
Latency 
Dog Occlusion (seconds) 
A Control 47 
Verapamil 115 
Control 67 
B Control 66 
Verapamil 205 
Control 80 
C Control 90 
Verapamil 330 
Control 238 
D Control 132 
Verapamil 205t 
Control 113 
E Control lOS 
Verapamil 330 
Control 149 
F Control 119 
Verapamil 330 
Control 100 
G Control 182 
Verapamil 330 
Control 83 
H Control 144 
Verapamil 330 
Control 175 
Percent 
Change 
+ 102 
+ 181 
+ 101 
+67 
+ 160 
+201 
+ 149 
+ 107 
Mean ± standard error + 134 ± 16.3* 
*p < 0.001. tRelease of occlusion was made because of apparent 
syncope associated with bradycardia. 
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Figure 2. Effects of verapamil and lidocaine ort conduction delay. 
The percent change from preocc\usion epicardial conduction delay 
to the maximal conduction delay achieved during occlusion is 
plotted on the ordinate. The type of experiment is indicated on 
the abscissa. NS == not significant. 
sion conduction delay) than for control experiments (70% 
increase); however, the difference did not reach significance 
(Fig. 2). All dogs demonstrating any increase in conduction 
delay during control occlusion showed that the rate at which 
conduction delay increased was retarded during verapamil 
occlusion as compared with control occlusion (Fig. 3). The 
peak conduction delay achieved during occlusion divided 
by the time elapsed from the start of occlusion to the ap-
pearance of peak delay was used as a measure of the rate 
of change in conduction delay. This value was reasonably 
reproducible for control experiments in a given dog, show-
ing a strong correlation (r = 0.91) for the first two control 
experiments. This value was significantly less for verapamil 
occlusions when compared with the control (Fig. 4). That 
is, conduction delay into the ischemic epicardium developed 
sooner after the start of occlusion during control experiments 
than during verapamiJ experiments. 
Lidocaine. Records were adequate to measure conduc-
tion delay in nine experiments in five dogs. Conduction 
deiay increased for all dogs during control occlusion (Fig. 
2). The mean change in conduction delay was greater for 
all lidocaine occlusions (94% increase of preocclusion con-
duction delay) than for control occlusions (78% increase). 
However, this did not reach significance. The rate at which 
conduction delay progressed after occlusion was not con-
sistently affected by lidocaine (Fig. 4). 
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Figure 3. The relation of the increase of epicardial conduction 
delay (ordinate) and the time after the onset of coronary occlusion 
(abscissa). Note that conduction delay increases more rapidly dur-
ing control occlusions compared with verapamil occlusion. Release 
of occlusion (arrows) was made when a repetitive ventricular 
response occurred and was followed by return of activation time 
toward baseline. 
Discussion 
Verapamil versus lidocaine. This study showed that 
verapamil decreased the occurrence of repetitive ventricular 
arrhythmias during ischemia in a conscious dog model with 
a previous myocardial infarction, whereas lidocaine had no 
Figure 4. Effect of verapamil and lidocaine on the rate at which 
conduction delay changes in the ischemic epicardium after occlu-
sion. The peak conduction delay (milliseconds) divided by the 
time after occlusion (seconds) at which this peak delay was first 
noted is plotted on the ordinate. The type of experiment is in-
dicated on the abscissa. NS = not significant. 
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such beneficial effect and even showed a detrimental effect 
as the incidence of ventricular fibrillation was increased. 
When ventricular arrhythmias did occur after pretreatment 
with verapamil, their grade was reduced and the time from 
start of occlusion to their appearance was delayed. These 
results would suggest that verapamil had a beneficial effect 
in this model. These observations are significant primarily 
because they were made using a conscious animal model, 
which is more analogous to the clinical state than are the 
anesthetized, open chest animals used in previous studies 
(9-16). This model is particularly attractive because ar-
rhythmias develop consistently after coronary occlusion and 
each animal may serve as its own control to identify and 
quantify antiarrhythmic interventions. 
The model does have a potentially significant limitation: 
occlusions are released with the appearance of repetitive 
ventricular complexes or after a maximal time of 5.5 minutes 
and not with the appearance of ventricular fibrillation. These 
criteria were used so that the conscious dog would not be 
subjected to repeated ventricular fibrillation and so that myo-
cardial infarction in the circumflex coronary bed would be 
avoided. The model appeared stable during successive con-
trol experiments. It could be argued that verapamil merely 
delayed the appearance of arrhythmia beyond the time of 
release of occlusion. However, an argument against this 
would be that when arrhythmias did appear with verapamil 
their grade was reduced. It is also possible that ventricular 
fibrillation might have occurred in control experiments had 
the occlusion not been released after the appearance of re-
petitive beats. But the increased incidence of ventricular 
fibrillation with lidocaine would suggest that a repetitive 
ventricular response is more likely to degenerate into ven-
tricular fibrillation in the presence of lidocaine. Thus, lido-
caine appears to facilitate ventricular fibrillation in this model. 
Because the conscious dog model imposes some con-
straints on making electrophysiologic and hemodynamic ob-
servations, it was not within the scope of this study to 
determine the mechanism of the effects of verapamil or 
lidocaine. However, electrophysiologic observations that al-
low some speculations on mechanisms were made. Vera-
pamil retarded the development of conduction delay into 
the ischemic epicardium. Lidocaine did not have a consistent 
effect on the rate at which conduction delay developed. 
Previous in vivo animal studies. Conscious animal 
models have been used to study the effects of beta-adren-
ergic blocking agents in spontaneous early arrhythmias that 
occur during coronary occlusion. Some studies demon-
strated pretreatment with beta-adrenergic blocking agents to 
be effective (18,19), whereas at least one different study 
showed propranolol to be ineffective (20). 
Most investigations of other antiarrhythmic agents on 
ischemia-induced arrhythmias have been performed in the 
anesthetized open chest animal. Several authors (10-13) 
demonstrated that verapamil pretreatment decreases the in-
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cidence of spontaneous ventricular fibrillation within the 
early arrhythmic phase of coronary occlusion in the anes-
thetized open chest canine model. To our knowledge this 
has not been demonstrated previously in a conscious animal 
mode. 
Among the antiarrhythmic agents that block fast chan-
nels, lidocaine has been investigated. The studies were done 
on anesthetized open chest animals and had diverse results. 
In a study by Borer et al. (14) the incidence of spontaneous 
ventricular fibrillation within 20 minutes of coronary oc-
clusion was decreased from 88 to 45% by pretreatment with 
lidocaine, resulting in levels between 1.2 and 5.5 jLg/ml. 
However, fibrillation occurred in all dogs with lidocaine 
levels greater than 5.5 jLg/ml. Hope et al. (15) studied the 
effect of lidocaine on ventricular tachycardia after abrupt 
coronary occlusion and found that it was not protective and 
did not influence time of onset of arrhythmias. In their study, 
lidocaine levels were not reported. Spear et al. (16) studied 
the effect of lidocaine on the ventricular fibrillation threshold 
measured as the minimal current needed for a train of pulses 
to induce ventricular fibrillation in an anesthetized open 
chest dog. These investigators found that lidocaine at blood 
levels of 1.2 to 5.5 jLg/ml reversed the decrease in fibril-
lation threshold accompanying acute myocardial ischemia 
produced within 2 minutes of coronary artery occlusion. 
Han et al. (17) used the response to double premature stimuli 
during ischemia in an' anesthetized open chest dog model 
as a measure of antiarrhythmic efficacy. Lidocaine at blood 
levels of 3 to 5 jLg/ml abolished single or mUltiple echo 
beats in 10 of 13 dogs. They concluded that lidocaine was 
effective in preventing ventricular reentrant activity during 
ischemia. 
VerapamiI: possible mechanisms of action. Although 
it has been theorized that a calcium channel blocker such 
as verapamil may be efficacious in preventing early ar-
rhythmias by converting unidirectional block into bidirec-
tional block and thereby abolishing reentry, this has not 
been demonstrated (21). Instead, previous studies 
(11,12.22,23) demonstrated that conduction into the isch-
emic epicardium improved with verapamil at a given time 
after occlusion. The present study extends those observa-
tions by demonstrating that verapamil improves conduction 
by retarding the development of conduction delay into the 
ischemic epicardium. Several authors (11,22) proposed that 
the seemingly paradoxical effects of verapamil on conduc-
tion velocity might be due to a reduction in the size of 
ischemic injury or degree of ischemia. In the present study, 
observation of verapamil retarding the development of con-
duction delay may reflect a slowing of the rate at which 
ischemia develops. 
Brooks et al. (13). however, concluded that the antifi-
brillatory action of verapamil during coronary artery occlu-
sion may be related, in part, to antagonism of enhanced 
adrenergic input into the heart. Thus, while the electro-
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physiologic mechanism for the effect of verapamil on early 
arrhythmias remains undefined, this agent shares several 
significant effects with propranolol and other beta-adren-
ergic blocking agents: l) beta-adrenergic blockade, 2) di-
minished degree of ischemia, and 3) possibly retarded rate 
at which ischemia develops. These may be significant an-
tiarrhythmic effects. 
Verapamil: effects on heart rate. Verapamil increased 
sinus rate before occlusion, although not significantly. New-
man et al. (24) previously demonstrated a tachycardia after 
verapamil administration in the normal conscious dog with 
an intact autonomic nervous system. They concluded that 
the most probable mechanism for this increase in heart rate 
was the baroreceptor reflex. They hypothesized that by means 
of this reflex a decrease in aortic pressure, due primarily to 
a decrease in total peripheral resistance, resulted in reflex 
vagal withdrawal and increased sympathetic stimulation as 
well. 
In the present study during coronary occlusion with ve-
rapamil pretreatment, an insignificant decrease in peak sinus 
heart rate was observed while second degree artrioventric-
ular block was seen in two of eight dogs and a marked and 
abrupt sinus bradycardia was observed in one dog. This 
tendency toward decreasing sinus rate and slowing of atrio-
ventricular conduction may have been due to the direct effect 
of verapamil added to the previously described vasode-
pressor response which occurs during ischemia of the in-
feroposterior left ventricle (25). 
Lidocaine: possible mechanisms of action. Lidocaine 
has been previously demonstrated to slow conduction into 
ischemic myocardium while having no significant effect on 
conduction into the normal zone (15,22,26). It has also been 
demonstrated to decrease the dispersion of ventricular re-
fractory periods between normal and ischemic myocardium 
in a 2 hour myocardial infarction (26). Thus, lidocaine may 
have antiarrhythmic effects by converting unidirectional block 
and reentry into bidirectional block, thus aborting reentry. 
The proarrhythmic effects of lidocaine in this model are 
unexplained. It should be noted that the present model dif-
fers from previous models in several ways: there is a pre-
vious infarction and a very large ischemic area and dogs 
are studied in the conscious state. It is possible that there 
are effects on conduction and possibly on ventricular re-
fractoriness that were not measurable in the present model 
which provoked arrhythmias. 
Clinical implications. In this conscious model ventric-
ular arrhythmias are produced by ischemia in the presence 
of a previous myocardial infarction in a remote vascular 
bed. Although this model is complex it has clinical relevance 
because many patients with out-of-hospital cardiac arrest 
have had a documented previous myocardial infarction 
(1,3,27). Ischemia was induced between 13 and 35 days 
after the prior myocardial infarction in this model. This 
would be analogous to the first month after hospital dis-
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charge in clinical myocardial infarction. Verapamil efficacy 
in the present model and previous studies (10-13) suggests 
that long-term verapamil and possibly other agents that de-
crease ischemia should be tested and compared with beta-
adrenergic agents in patients after myocardial infarction. 
Lidocaine was administered before the onset of coronary 
occlusion in the present study. In the coronary care unit 
lidocaine is generally given after the onset of occlusion. 
Thus, our model is more analogous to the patient with prior 
myocardial infarction given a long-term fast channel block-
ing antiarrhythmic agent who has ischemia after hospital 
discharge. The effect of lidocaine in this model suggests 
that a prophylactically administered fast channel blocking 
antiarrhythmic agent may have a detrimental effect in the 
presence of a large area of ischemia and a previous myo-
cardial infarction. Further investigations are needed to de-
termine the efficacy of other fast channel blocking antiar-
rhythmic agents administered before the onset of ischemia 
in animal models with previous myocardial infarction. 
We express our appreciation to Pam Brewster for assistance in the statistical 
analysis of the data. 
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